Literature DB >> 30721165

Prescription Drug Monitoring Programs and Opioid Overdoses: Exploring Sources of Heterogeneity.

Alvaro Castillo-Carniglia1,2, William R Ponicki3, Andrew Gaidus3, Paul J Gruenewald3, Brandon D L Marshall4, David S Fink5, Silvia S Martins5, Ariadne Rivera-Aguirre1, Garen J Wintemute1, Magdalena Cerdá1,6.   

Abstract

BACKGROUND: Prescription drug monitoring program are designed to reduce harms from prescription opioids; however, little is known about what populations benefit the most from these programs. We investigated how the relation between implementation of online prescription drug monitoring programs and rates of hospitalizations related to prescription opioids and heroin overdose changed over time, and varied across county levels of poverty and unemployment, and levels of medical access to opioids.
METHODS: Ecologic county-level, spatiotemporal study, including 990 counties within 16 states, in 2001-2014. We modeled overdose counts using Bayesian hierarchical Poisson models. We defined medical access to opioids as the county-level rate of hospital discharges for noncancer pain conditions.
RESULTS: In 2010-2014, online prescription drug monitoring programs were associated with lower rates of prescription opioid-related hospitalizations (rate ratio 2014 = 0.74; 95% credible interval = 0.69, 0.80). The association between online prescription drug monitoring programs and heroin-related hospitalization was also negative but tended to increase in later years. Counties with lower rates of noncancer pain conditions experienced a lower decrease in prescription opioid overdose and a faster increase in heroin overdoses. No differences were observed across different county levels of poverty and unemployment.
CONCLUSIONS: Areas with lower levels of noncancer pain conditions experienced the smallest decrease in prescription opioid overdose and the faster increase in heroin overdose following implementation of online prescription drug monitoring programs. Our results are consistent with the hypothesis that prescription drug monitoring programs are most effective in areas where people are likely to access opioids through medical providers.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30721165      PMCID: PMC6437666          DOI: 10.1097/EDE.0000000000000950

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  31 in total

1.  A multilevel analysis of neighborhood context and youth alcohol and drug problems.

Authors:  Susan C Duncan; Terry E Duncan; Lisa A Strycker
Journal:  Prev Sci       Date:  2002-06

2.  Effect of abuse-deterrent formulation of OxyContin.

Authors:  Theodore J Cicero; Matthew S Ellis; Hilary L Surratt
Journal:  N Engl J Med       Date:  2012-07-12       Impact factor: 91.245

3.  Poisson, Poisson-gamma and zero-inflated regression models of motor vehicle crashes: balancing statistical fit and theory.

Authors:  Dominique Lord; Simon P Washington; John N Ivan
Journal:  Accid Anal Prev       Date:  2005-01

4.  Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United States.

Authors:  Katherine M Keyes; Magdalena Cerdá; Joanne E Brady; Jennifer R Havens; Sandro Galea
Journal:  Am J Public Health       Date:  2013-12-12       Impact factor: 9.308

5.  Blacks and Hispanics are less likely than whites to complete addiction treatment, largely due to socioeconomic factors.

Authors:  Brendan Saloner; Benjamin Lê Cook
Journal:  Health Aff (Millwood)       Date:  2013-01       Impact factor: 6.301

6.  Association between opioid prescribing patterns and opioid overdose-related deaths.

Authors:  Amy S B Bohnert; Marcia Valenstein; Matthew J Bair; Dara Ganoczy; John F McCarthy; Mark A Ilgen; Frederic C Blow
Journal:  JAMA       Date:  2011-04-06       Impact factor: 56.272

7.  Prescription drug monitoring programs and death rates from drug overdose.

Authors:  Leonard J Paulozzi; Edwin M Kilbourne; Hema A Desai
Journal:  Pain Med       Date:  2011-02-18       Impact factor: 3.750

8.  The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic noncancer pain: the role of opioid prescription.

Authors:  Mark J Edlund; Bradley C Martin; Joan E Russo; Andrea DeVries; Jennifer B Braden; Mark D Sullivan
Journal:  Clin J Pain       Date:  2014-07       Impact factor: 3.442

9.  "Every 'never' I ever said came true": transitions from opioid pills to heroin injecting.

Authors:  Sarah G Mars; Philippe Bourgois; George Karandinos; Fernando Montero; Daniel Ciccarone
Journal:  Int J Drug Policy       Date:  2013-10-19

10.  Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: the TROUP study.

Authors:  Mark D Sullivan; Mark J Edlund; Ming-Yu Fan; Andrea DeVries; Jennifer Brennan Braden; Bradley C Martin
Journal:  Pain       Date:  2008-06-10       Impact factor: 6.961

View more
  13 in total

1.  Prescription Drug Monitoring Programs and Prescription Opioid-Related Outcomes in the United States.

Authors:  Victor Puac-Polanco; Stanford Chihuri; David S Fink; Magdalena Cerdá; Katherine M Keyes; Guohua Li
Journal:  Epidemiol Rev       Date:  2020-01-31       Impact factor: 6.222

2.  Methodological Challenges and Proposed Solutions for Evaluating Opioid Policy Effectiveness.

Authors:  Megan S Schuler; Beth Ann Griffin; Magdalena Cerdá; Emma E McGinty; Elizabeth A Stuart
Journal:  Health Serv Outcomes Res Methodol       Date:  2020-11-12

3.  When Effects Cannot be Estimated: Redefining Estimands to Understand the Effects of Naloxone Access Laws.

Authors:  Kara E Rudolph; Catherine Gimbrone; Ellicott C Matthay; Iván Díaz; Corey S Davis; Katherine Keyes; Magdalena Cerdá
Journal:  Epidemiology       Date:  2022-06-24       Impact factor: 4.860

4.  The Impact of a PDMP-EHR Data Integration Combined With Clinical Decision Support on Opioid and Benzodiazepine Prescribing Across Clinicians in a Metropolitan Area.

Authors:  Susan L Calcaterra; Maria Butler; Katie Olson; Joshua Blum
Journal:  J Addict Med       Date:  2022 May-Jun 01       Impact factor: 4.647

5.  A Rapid Review of the Impact of Systems-Level Policies and Interventions on Population-Level Outcomes Related to the Opioid Epidemic, United States and Canada, 2014-2018.

Authors:  Bahareh Ansari; Katherine M Tote; Eli S Rosenberg; Erika G Martin
Journal:  Public Health Rep       Date:  2020 Jul/Aug       Impact factor: 2.792

6.  Transitioning from pharmaceutical opioids: A discrete-time survival analysis of heroin initiation in suburban/exurban communities.

Authors:  T L Gaines; K D Wagner; M L Mittal; J M Bowles; E Copulsky; M Faul; R W Harding; P J Davidson
Journal:  Drug Alcohol Depend       Date:  2020-05-28       Impact factor: 4.492

7.  Listed for sale: Analyzing data on fentanyl, fentanyl analogs and other novel synthetic opioids on one cryptomarket.

Authors:  Francois R Lamy; Raminta Daniulaityte; Monica J Barratt; Usha Lokala; Amit Sheth; Robert G Carlson
Journal:  Drug Alcohol Depend       Date:  2020-06-12       Impact factor: 4.492

8.  Difference-in-Difference in the Time of Cholera: a Gentle Introduction for Epidemiologists.

Authors:  Ellen C Caniglia; Eleanor J Murray
Journal:  Curr Epidemiol Rep       Date:  2020-09-23

9.  Advances in prescription drug monitoring program research: a literature synthesis (June 2018 to December 2019).

Authors:  Chris Delcher; Nathan Pauly; Patience Moyo
Journal:  Curr Opin Psychiatry       Date:  2020-07       Impact factor: 4.787

10.  Predicting the Future Course of Opioid Overdose Mortality: An Example From Two US States.

Authors:  Natalie Sumetsky; Christina Mair; Katherine Wheeler-Martin; Magdalena Cerda; Lance A Waller; William R Ponicki; Paul J Gruenewald
Journal:  Epidemiology       Date:  2021-01       Impact factor: 4.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.